Microthrombosis after aneurysmal subarachnoid hemorrhage: An additional explanation for delayed cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 11, 2008, Pages 1761-1770

  Vergouwen, Mervyn D I ^a,b   Vermeulen, Marinus ^a   Coert, Bert A ^a   Stroes, Erik S G ^a   Roos, Yvo B W E M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Delayed cerebral ischemia; Microthrombosis; Pathogenesis; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BLOOD CLOTTING FACTOR; CLAZOSENTAN; ENOXAPARIN; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; TAK 044; TRANEXAMIC ACID;

AUTOPSY; BLOOD CLOTTING; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASOSPASM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; DELAYED BRAIN ISCHEMIA; ENCEPHALITIS; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; MICROTHROMBUS; NEUROPATHOLOGY; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; SEROLOGY; SUBARACHNOID HEMORRHAGE; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

BRAIN ISCHEMIA; CORONARY THROMBOSIS; HUMANS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 54949118311     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.74     Document Type: Review

References (91)

1. Amin-Hanjani S, Ogilvy CS, Barker FG, II (2004) Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326-34
2. Barth M, Capelle HH, Münch E, Thomé C, Fiedler F, Schmiedek P, Vajkoczy P (2007) Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Acta Neurochir (Wien) 149:911-8
3. Crompton MR (1964) The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 87:491-510
4. Dehdashti AR, Mermillod B, Rufenacht DA, Reverdin A, de Tribolet N (2004) Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 17:53-60
5. Dietrich WD, Feng ZC, Leistra H, Watson BD, Rosenthal M (1994) Photothrombotic infarction triggers multiple episodes of cortical spreading depression in distant brain regions. J Cereb Blood Flow Metab 14:20-8
6. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, Reuter U, Imai Y, Einhäupl KM, Victorov I, Dirnagl U (2000) Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 93:658-66
7. Dreier JP, Körner K, Ebert N, Görner A, Rubin I, Back T, Lindauer U, Wolf T, Villringer A, Einhäupl KM, Lauritzen M, Dirnagl U (1998) Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 18:978-90
8. Dreier JP, Kremer C, Lammers G, Lohmann F, Hansen HC, Valdueza JM (2007) Migraine and delayed ischaemic neurological deficit after subarachnoid haemorrhage in women: a case-control study. Eur J Neurol 14:1363-8
9. Dreier JP, Sakowitz OW, Harder A, Zimmer C, Dirnagl U, Valdueza JM, Unterberg AW (2002) Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Ann Neurol 52:825-9
10. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann TN, Sarrafzadeh A, Willumsen L, Hartings JA, Sakowitz OW, Seemann JH, Thieme A, Lauritzen M, Strong AJ (2006) Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129:3224-37
11. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876-83
12. Fergusen S, Macdonald RL (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658-67
13. Findlay JM, Kassell NF, Weir BK, Haley Jr EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn HR, Ferguson G (1995) A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:168-76
14. Fisher CM, Roberson GH, Ojemann RG (1977) Cerebral vasospasm with ruptured saccular aneurysm - the clinical manifestations. Neurosurgery 1:245-8
15. Frijns CJ, Fijnheer R, Algra A, van Mourik JA, van Gijn J, Rinkel GJ (2006a) Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry 77:77-83
16. Frijns CJ, Kasius KM, Algra A, Fijnheer R, Rinkel GJ (2006b) Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77:863-7
17. Giller CA, Giller AM, Landreneau F (1998) Detection of emboli after surgery for intracerebral aneurysms. Neurosurgery 42:490-3
18. Hendryk S, Jarzab B, Josko J (2004) Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 25:141-7
19. Herz DA, Baez S, Shulman K (1975) Pial microcirculation in subarachnoid hemorrhage. Stroke 6:417-24
20. Hijdra A, Van Gijn J, Stefanko S, Van Dongen KJ, Vermeulen M, Van Crevel H (1986) Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology 36:329-33
21. Hirashima Y, Nakamura S, Endo S, Kuwayama N, Naruse Y, Takaku A (1997a) Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 22:1249-55
22. Hirashima Y, Nakamura S, Suzuki M, Kurimoto M, Endo S, Ogawa A, Takaku A (1997b) Cerebrospinal fluid tissue factor and thrombin-antithrombin III complex as indicators of tissue injury after subarachnoid hemorrhage. Stroke 28:1666-70
23. Hughes JT, Schianchi PM (1978) Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48:515-25
24. Ikeda K, Asakura H, Futami K, Yamashita J (1997) Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 41:344-9
25. Itoyama Y, Fujioka S, Takaki S, Morioka M, Hide T, Ushio Y (1994) Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage. Neurosurgery 35:1055-60
26. Jestaedt L, Pham M, Bartsch AJ, Kunze E, Roosen K, Solymosi L, Bendszus M (2008) The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 62:610-7
27. Juvela S (2000) Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg 92:390-400
28. Kasuya H, Shimizu T, Takakura K (1998) Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm. Acta Neurochir (Wien) 140:579-84
29. Kawada S, Kinugasa K, Meguro T, Hirotsune N, Tokunaga K, Kamata I, Nakashima H, Ohmoto T (1999) Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir (Wien) 141:1331-8
30. Kawamoto S, Tsutsumi K, Yoshikawa G, Shinozaki MH, Yako K, Nagata K, Ueki K (2004) Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 100:236-43
31. Kessler IM, Pacheco YG, Lozzi SP, de Araujo AS, Jr, Onishi FJ, de Mello PA (2005) Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 64(Suppl 1):2-5
32. Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T (2004) Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo) 44:569-75
33. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP (2008) Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 62:422-7
34. Krysiak R, Okopien B, Herman Z (2003) Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs 63:1821-54
35. Lee JY, Lee MS, Whang K, Lee JM, Kim SH, Lee SS (2006) Accuracy of transcranial Doppler sonography for predicting cerebral infarction in aneurysmal subarachnoid hemorrhage. J Clin Ultrasound 34:380-4
36. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698-704
37. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT (2005) Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36:2024-6
38. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R (2004) Magnesium and experimental vasospasm. J Neurosurg 100:106-10
39. Mastrogiannis DS, Kalter CS, O'Brien WF, Carlan SJ, Reece EA (1992) Effect of magnesium sulfate on plasma endothelin-1 levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol 167:1554-9
40. McGirt MJ, Blessing R, Alexander MJ, Nimjee SM, Woodworth GF, Friedman AH, Graffagnino C, Laskowitz DT, Lynch JR (2006) Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience. J Neurosurg 105:671-4
41. Minhas PS, Menon DK, Smielewski P, Czosnyka M, Kirkpatrick PJ, Clark JC, Pickard JD (2003) Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 52:1017-22
42. Naidech AM, Drescher J, Tamul P, Shaibani A, Batjer HH, Alberts MJ (2006) Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77:1340-4
43. Nassar T, Akkawi S, Shina A, Haj-Yehia A, Bdeir K, Tarshis M, Heyman SN, Higazi AA (2004) In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone. Blood 103:897-902
44. Neil-Dwyer G, Lang DA, Doshi B, Gerber CJ, Smith PW (1994) Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir (Wien) 131:137-45
45. Nina P, Schisano G, Chiappetta F, Luisa Papa M, Maddaloni E, Brunori A, Capasso F, Corpetti MG, Demurtas F (2001) A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome. Surg Neurol 55:197-203
46. Nissen JJ, Mantle D, Gregson B, Mendelow AD (2001) Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry 71:329-33
47. Ohkuma H, Itoh K, Shibata S, Suzuki S (1997) Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs. Neurosurgery 41:230-5
48. Ohkuma H, Suzuki S, Kimura M, Sobata E (1991) Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22:854-9
49. Ohta H, Ito Z (1981) Cerebral infraction due to vasospasm, revealed by computed tomography. Neurol Med Chir (Tokyo) 21:365-72
50. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J (1998) Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 140:943-51
51. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly Jr ES (2005) Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56:476-484
52. Peltonen S, Juvela S, Kaste M, Lassila R (1997) Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 87:207-14
53. Perkins E, Kimura H, Parent AD, Zhang JH (2002) Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 97:896-904
54. Piñero P, González A, Mayol A, MartÍnez E, González-Marcos JR, Boza F, Cayuela A, Gil-Peralta A (2006) Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. AJNR Am J Neuroradiol 27:1338-45
55. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF (2000) Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92:284-90
56. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, Atkinson JL, Wijdicks EF (2004) Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 35:1862-6
57. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF (2005) Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36:992-7
58. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL (2004) Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 101:255-61
59. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2005) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (1): CD000277
60. Romano JG, Forteza AM, Concha M, Koch S, Heros RC, Morcos JJ, Babikian VL (2002) Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 50:1026-30
61. Roos Y (2000) Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54:77-82
62. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M (2000) Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in The Netherlands. J Neurol Neurosurg Psychiatry 68:337-41
63. Roos YB, Levi M, Carroll TA, Beenen LF, Vermeulen M (2001) Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32:1860-2
64. Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J (2003) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (1):CD001245
65. Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM (2000) Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992-7
66. Shin HK, Dunn AK, Jones PB, Boas DA, Moskowitz MA, Ayata C (2006) Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 26:1018-30
67. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953-9
68. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ (2005) SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64:1008-13
69. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI (2006) Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 59:781-7
70. Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T (1998) Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage. Neurol Res 20:625-31
71. Suzuki M, Kudo A, Otawara Y, Hirashima Y, Takaku A, Ogawa A (1999) Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery 44:487-93
72. Suzuki S, Kimura M, Souma M, Ohkima H, Shimizu T, Iwabuchi T (1990) Cerebral microthrombosis in symptomatic cerebral vasospasm - a quantitative histological study in autopsy cases. Neurol Med Chir (Tokyo) 30:309-16
73. Suzuki S, Suzuki M, Iwabuchi T, Kamata Y (1983) Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report. Neurosurgery 13:199-203
74. Treggiari MM, Walder B, Suter PM, Romand JA (2003) Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-84
75. Tsementzis SA, Hitchcock ER, Meyer CH (1990) Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien) 102:1-10
76. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2005) Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36:1627-32
77. Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ (2007) Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38:1545-50
78. Uhl E, Lehmberg J, Steiger HJ, Messmer K (2003) Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 52:1307-15
79. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9-17
80. van den Bergh WM, MASH Study Group (2006) Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke 37:2326-30
81. Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M (2004) Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:1280-3
82. Vergouwen MD, Vermeulen M, de Haan RJ, Levi M, Roos YB (2007) Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab 27:1293-308
83. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J (1984) Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:432-7
84. Vermeulen M, van Vliet HH, Lindsay KW, Hijdra A, van Gijn J (1985) Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage. J Neurosurg 63:573-7
85. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM (1999) Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44:1237-47
86. Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J (2007) Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 38:1831-6
87. Weidauer S, Vatter H, Beck J, Raabe A, Lanfermann H, Seifert V, Zanella F (2008) Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage. Neuroradiology 50:1-8
88. Wolf O, Heider P, Heinz M, Poppert H, Sander D, Greil O, Weiss W, Hanke M, Eckstein HH (2004) Microembolic signals detected by transcranial Doppler sonography during carotid endarterectomy and correlation with serial diffusion-weighted imaging. Stroke 35:e373-5
89. Wong GK, Chan MT, Boet R, Poon WS, Gin T (2006) Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 18:142-8
90. Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K (2004) Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a doubleblind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 106:97-103
91. Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, Newell D, Verweij B, Bullock MR, Baker A, Coplin W, Mericle R, Dai J, Rocke D, Muizelaar JP (2008) Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage. Results of a phase II multicenter, randomized, clinical trial. Stroke 39:1759-65